Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.43K Hold
140
﹤0.01% 480
2026
Q1
$8.79K Hold
140
﹤0.01% 448
2025
Q4
$9.29K Hold
140
﹤0.01% 318
2025
Q3
$9.42K Hold
140
﹤0.01% 484
2025
Q2
$12.2K Hold
140
﹤0.01% 477
2025
Q1
$9.56K Buy
+140
New +$11.4K ﹤0.01% 512
2024
Q1
Sell
-10
Closed -$1.24K 602
2023
Q4
$1.24K Buy
+10
New +$1.02K ﹤0.01% 780

Other funds holding DXCM

Arlington Trust's DXCM Position: Q2 2026 in Review

Arlington Trust held its DexCom (DXCM) position steady in Q2 2026 at 140 shares worth $9.43K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Arlington Trust first reported a position in DXCM in Q4 2023 and has held it in 7 quarters since. The position peaked at $12.2K in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Arlington Trust held 140 shares of DexCom worth $9.43K as of Q2 2026.
  • Arlington Trust left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #480 holding.
  • Arlington Trust first reported a position in DexCom in Q4 2023 and has held it in 7 quarters since.
  • Arlington Trust's DexCom position peaked at $12.2K in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.